KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Deferred Revenue (2017 - 2025)

Historic Current Deferred Revenue for Globus Medical (GMED) over the last 9 years, with Q3 2025 value amounting to $18.3 million.

  • Globus Medical's Current Deferred Revenue fell 1218.63% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year decrease of 1218.63%. This contributed to the annual value of $22.1 million for FY2024, which is 2052.92% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Current Deferred Revenue is $18.3 million, which was down 1218.63% from $24.0 million recorded in Q2 2025.
  • Globus Medical's Current Deferred Revenue's 5-year high stood at $24.0 million during Q2 2025, with a 5-year trough of $8.7 million in Q1 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $14.9 million (2023), whereas its average is $15.5 million.
  • As far as peak fluctuations go, Globus Medical's Current Deferred Revenue soared by 5644.93% in 2021, and later plummeted by 1218.63% in 2025.
  • Over the past 5 years, Globus Medical's Current Deferred Revenue (Quarter) stood at $12.0 million in 2021, then grew by 17.26% to $14.1 million in 2022, then surged by 30.28% to $18.4 million in 2023, then increased by 20.53% to $22.1 million in 2024, then decreased by 17.49% to $18.3 million in 2025.
  • Its Current Deferred Revenue was $18.3 million in Q3 2025, compared to $24.0 million in Q2 2025 and $17.2 million in Q1 2025.